Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: February 2021

MissionIRNewsBreaks – Augusta Gold Inc. (CSE: G) (OTCQB: BFGCD) (FSE: 11B) Announces C$15M Fully Subscribed Private Placement

Posted on February 10, 2021 by MissionIR

Augusta Gold (CSE: G) (OTCQB: BFGCD) (FSE: 11B) today announced a fully subscribed non-brokered private placement raising approximately C$15 million. Per the private placement, Augusta will offer 6.7 million units at a price of C$2.25 per unit with each unit … Continue reading →

Posted in Augusta Gold Inc. BFGCD | Leave a comment

MissionIRNewsBreaks – TAAT(TM) Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) Announces 233% Manufacturing Increase of Flagship Product

Posted on February 10, 2021 by MissionIR

TAAT(TM) (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) today announced that its flagship product TAAT(TM) is now being manufactured at a rate of more than 57,000 ten-pack cartons per month (over 690,000 cartons per year). According to the update, this represents … Continue reading →

Posted in TAAT Lifestyle & Wellness Ltd. TOBAF | Leave a comment

MissionIRNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Studying Potential for Psychedelics in Treatment of Mental Health Conditions, Announces Addition of Mescaline to Subsidiary Medicine Programs

Posted on February 10, 2021 by MissionIR

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator at the leading-edge of the life science industry, is involved in preclinical laboratory work designed to study a variety of psychotropic compounds, including psilocybin, mescaline, LSD, MDMA and DMT. The … Continue reading →

Posted in MissionIRNewsBreaks, XPhyto Therapeutics Corp. XPHYF | Leave a comment

MissionIRNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Preparing Phase 3 Trial to Evaluate Neuroactive Nasal Spray Treatment for SAD

Posted on February 10, 2021 by MissionIR

VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company developing new-generation medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (“CNS”) disorders, has announced plans to begin a Phase 3 clinical … Continue reading →

Posted in MissionIRNewsBreaks, VistaGen Therapeutics Inc. VTGN | Leave a comment

Knightscope’s Modern “Round Table” is an IoT, AI-enabled Operations Center that Delivers Robotic Security 24/365 Nationwide

Posted on February 9, 2021 by MissionIR

Silicon Valley-based Knightscope produces autonomous security robots (“ASRs”) that provide indoor and outdoor security 24 hours a day, 365 days a year Knightscope’s ASRs surveil client properties using an array of artificial intelligence, machine learning and Internet of Things tools … Continue reading →

Posted in Small Cap News | Leave a comment

MissionIRNewsBreaks – Siyata Mobile Inc. (NASDAQ: SYTA) (TSX.V: SIM) Announces New Chairman, Member to Board of Directors

Posted on February 9, 2021 by MissionIR

Siyata Mobile (NASDAQ: SYTA, SYTAW) (TSX.V: SIM), a leading global developer and provider of Push-to-Talk Over Cellular (“PTT/PoC”) systems for enterprise customers, has appointed Peter Goldstein, currently a Siyata Board member, as chairman of its Board of Directors; the company … Continue reading →

Posted in Siyata Mobile Inc. SYTA | Leave a comment

MissionIRNewsBreaks – Kaival Brands Innovations Group Inc. (KAVL) Announces Bidi Vapor Received FDA PMTA Acceptance Letter for all 11 Bidi Stick Products

Posted on February 9, 2021 by MissionIR

Kaival Brands (OTCQB: KAVL), a company focused on generating shareholder value by incubating innovative products into mature and dominant brands within their respective markets, has announced that Bidi(R) Vapor has received a PMTA acceptance letter from the U.S. Food and Drug … Continue reading →

Posted in Kaival Brands Innovations Group Inc. KAVL | Leave a comment

MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Appoints Technology Innovator to Lead MedCheks LLC

Posted on February 9, 2021 by MissionIR

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and health care platform, today announced its appointment of technology entrepreneur and industry thought leader James Ram to lead the company’s newly launched MedCheks LLC subsidiary. This move is part of … Continue reading →

Posted in Trxade Group Inc. (MEDS) | Leave a comment

MissionIRNewsBreaks — MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Releases Further Lab Results Validating Natural Biopesticide Control of Banana Disease

Posted on February 9, 2021 by MissionIR

MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0), an agriculture biotech company focused on providing natural science-based biological solutions for high-value crops, as released additional lab results confirming its mustard-derived natural biopesticide ability to obtain 100% control of on … Continue reading →

Posted in MustGrow Biologics Corp. MGROF | Leave a comment

MissionIRNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) (OTC: CBDHF) (FWB: 8OO) CMO to Serve 2nd Consecutive Term as President of US Hemp Roundtable

Posted on February 9, 2021 by MissionIR

HempFusion Wellness (TSX: CBD.U) (OTC: CBDHF) (FWB: 8OO), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, today announced that its Chief Marketing Officer, Ola Lessard, was elected president of the U.S. Hemp Roundtable for … Continue reading →

Posted in HempFusion Wellness Inc. CBD.U | Leave a comment